On February 6, 2023, MedAvail Holdings, Inc. and Steven Hess, the Company's Executive Vice President and General Manager of SpotRx, mutually agreed that Mr. Hess would resign from the Company effective as of February 17, 2023. In addition, on February 9, 2023, the Company and Matt Broome, the Company's Executive Vice President and General Manager of Technology, mutually agreed that Mr. Broome would resign from the Company effective as of February 10, 2023. Messrs.

Hess's and Broome's resignations are in connection with the Company's previously announced plans to exit the pharmacy services business to focus on the Company's pharmacy technology business and are not the result of any disagreement with the Company or its Board of Directors or any matter relating to the Company's operations, policies, or practices.